Evidence map›Paper›PMID 31670617›Full record

ArticleJournal of psychopharmacology (Oxford, England)2020

Lithium-associated hypothyroidism and potential for reversibility after lithium discontinuation: Findings from the LiSIE retrospective cohort study.

Ingrid Lieber, Michael Ott, Louise Öhlund, Robert Lundqvist, Mats Eliasson, Mikael Sandlund, Ursula Werneke

Open access · hybridAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ingrid LieberDepartment of Clinical Sciences, Division of Psychiatry, Umeå University, Sunderby Research Unit, Luleå, Sweden.ORCID 0000-0002-3536-6227
Michael OttDepartment of Public Health and Clinical Medicine - Medicine, Umeå University, Umeå, Sweden.
Louise ÖhlundDepartment of Clinical Sciences, Division of Psychiatry, Umeå University, Sunderby Research Unit, Luleå, Sweden.
Robert LundqvistResearch and Innovation Unit, Norrbotten Region, Luleå, Sweden.
Mats EliassonDepartment of Public Health and Clinical Medicine, Umeå University, Sunderby Research Unit, Luleå, Sweden.
Mikael SandlundDepartment of Clinical Sciences, Division of Psychiatry, Umeå University, Umeå, Sweden.
Ursula WernekeDepartment of Clinical Sciences, Division of Psychiatry, Umeå University, Sunderby Research Unit, Luleå, Sweden.ORCID 0000-0002-5023-3254
Umeå University · SEArctic Business Incubator (Sweden) · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association between lithium and thyroid dysfunction has long been known. However, it remains unknown if lithium-associated hypothyroidism is reversible once lithium treatment has been stopped.

aimsTo determine whether lithium-associated hypothyroidism was reversible in patients who subsequently discontinued lithium.

methodsA retrospective cohort study in the Swedish region of Norrbotten into the effects and side- effects of lithium treatment and other drugs for relapse prevention (Lithium - Study into Effects and Side Effects). For this particular study, we reviewed medical records between 1997 and 2015 of patients with lithium-associated hypothyroidism who had discontinued lithium.

resultsOf 1340 patients screened, 90 were included. Of these, 27% had overt hypothyroidism at the start of thyroid replacement therapy. The mean delay from starting lithium to starting thyroid replacement therapy was 2.3 years (SD 4.7). In total, 50% of patients received thyroid replacement therapy within 10 months of starting lithium. Of 85 patients available for follow-up, 41% stopped thyroid replacement therapy after lithium discontinuation. Only six patients reinstated thyroid replacement therapy subsequently. Of these, only one had overt hypothyroidism.

conclusionsLithium-associated hypothyroidism seems reversible in most patients once lithium has been discontinued. In such cases, thyroid replacement therapy discontinuation could be attempted much more often than currently done. Based on the limited evidence of our study, we can expect hypothyroidism to recur early after thyroid replacement therapy discontinuation, if at all.

Indexed as

AdolescentAdultAgedAged, 80 and overDrug UtilizationFemaleHumansHypothyroidismLithium CompoundsMaleMiddle AgedRetrospective StudiesSwedenThyroxineWithholding TreatmentYoung AdultLithium CompoundsThyroxineadverse effectBipolar disorderhypothyroidismlithiumthyroxine

Identifiers

PMID31670617
PMCPMC7005931
OpenAlexW2982509952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.